D'Amico Andrew sold $439K of VICR

D'Amico Andrew sold 1,216 shares of VICOR CORP (VICR) at an average of $360.77 ($354.12–$367.10, $0.44M total) across 7 trades on 2026-06-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · D'Amico Andrew
Published Jun 24, 2026, 4:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 24, 2026, 4:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

A director’s open-market sale under a 10b5-1 plan is generally not a strong fundamental signal, but it can influence short-term sentiment and positioning.

02

Market read

Traders may monitor for follow-on insider activity, but the disclosure alone is unlikely to drive a major repricing without accompanying fundamentals.

03

What to watch

The weighted-average price range ($354.12–$367.10) and the fact the director ends with 0 shares could matter for short-term sentiment, even if the plan reduces interpretability.

Relevance 3/10Novelty 5/10Timing: just filed Form 4 (filed 2026-06-24) disclosing 2026-06-22 insider sales

Background

The article is an SEC Form 4 insider transaction disclosure for ViCOR Corp (VICR).

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

ViCOR Corp director Andrew D'Amico sold $438,702 of VICR shares via an open-market sale under a 10b5-1 plan, leaving 0 shares.

Expected impact

Likely limited immediate price impact; any effect is more sentiment/flow-driven than fundamental.

Evidence & confidence

The filing is a primary Form 4 disclosure, but it specifies a pre-arranged 10b5-1 plan and the transaction size is modest versus typical market caps, reducing fundamental read-through.

Market effects

No direct sector catalyst; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.

Key entities

  • VICOR CORP

    ViCOR Corp (VICR) disclosed an insider sale by director Andrew D'Amico via Form 4.

  • Andrew D'Amico

    Director who sold 1,216 shares across seven trades; holdings after transaction: 0 shares.

  • 10b5-1 plan

    Pre-arranged plan noted as Yes, indicating the sale was scheduled in advance.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VICRMed

VICR SWOT Analysis: Strong Revenue Growth and Patent Settlement

Vicor Corp (VICR) reported Q3 2026 revenue of $197.1M, up 78.5% YoY, driven by product sales and royalty revenue. Gross margin increased to 68.3%. The company has a strong order backlog of $406M but faces valuation concerns and customer concentration risks. It has growth opportunities in EVs and renewable energy. VICR's GF Score is 82/100, with high growth and profitability ratings but low valuation.

$VICRHigh

VICR Stock Surges On Blowout Q3 And Aggressive Capacity Bet

Vicor Corporation (VICR) stock rose 12.95% after reporting Q3 2026 revenue of $197.1M, up 78.5% YoY, with gross margin at 68.3%. The company's backlog and operating cash flow increased, driven by AI and high-performance systems demand. VICR is expanding capacity and faces an ITC investigation. Analysts raised price targets to $350-$360.

$VICRHighAI 8/10

Why is Vicor stock climbing today?

Vicor Corporation (VICR) stock rose 2.6% in morning trading, extending gains after its Q3 2026 earnings beat expectations. Revenue was $197.1M, up 78.5% YoY, with adjusted EPS of $1.33. Gross margin expanded to 68.3%, and the order backlog grew 166% YoY to $406M. Analysts maintained Buy ratings with price targets of $350 and $375. The stock traded at $209.36, above its 52-week low of $79 but below its high of $382.65.